LATEST NEWS    Scientex posts lower 3Q 2025 profit of RM133.99 mln, revenue edges up to RM1.11 bln | The total collection from the Sales and Service Tax (SST) is expected to increase by RM5 billion in 2025 and RM10 billion in 2026 following its review and scope expansion — MOF | Inflation rate is expected to be under control at 0.25 per cent after the implementation of the expanded SST beginning July 1 -- MOF | Expanded SST seen collecting extra RM10bln in 2026 and RM5 bln in 2025 - MOF | ConocoPhillips eyes to invest in Sabah, in talks with Petronas on opportunities, and reaffirms commitment to invest in Malaysia – CEO | Scientex posts lower 3Q 2025 profit of RM133.99 mln, revenue edges up to RM1.11 bln | The total collection from the Sales and Service Tax (SST) is expected to increase by RM5 billion in 2025 and RM10 billion in 2026 following its review and scope expansion — MOF | Inflation rate is expected to be under control at 0.25 per cent after the implementation of the expanded SST beginning July 1 -- MOF | Expanded SST seen collecting extra RM10bln in 2026 and RM5 bln in 2025 - MOF | ConocoPhillips eyes to invest in Sabah, in talks with Petronas on opportunities, and reaffirms commitment to invest in Malaysia – CEO |

Top 20 Startups Join MedTech Innovator’s 2025 APAC Accelerator

KUALA LUMPUR, June 3 (Bernama) -- MedTech Innovator, the world’s largest accelerator of medical technology companies, has announced that 20 high-potential medtech companies will participate in the sixth annual Asia Pacific (APAC) Accelerator programme.

MedTech Innovator APAC managing director, Fredrik Nyberg in a statement said: “This year’s cohort is tackling some of the most pressing challenges in healthcare with bold ideas and transformative technologies.

“We are excited to support their journey, connect them with key industry partners, and accelerate their path to market, ultimately improving patient outcomes across APAC and globally.”

MedTech Innovator APAC unites best-in-class startups with investors, business leaders, and allied service professionals in the medtech industry to help drive the commercialisation of life-changing technologies in the region.

The 2025 cohort companies will also compete for up to US$300,000 in non-dilutive cash prizes and awards. (US$1=RM4.21)

More than 550 companies applied for the APAC programme this year, and after a rigorous selection process, 60 companies were invited to pitch, 20 of which were named to the 2025 cohort.

The Asia Pacific Accelerator 2025 Cohort will attend the programme’s kick-off, joining the MedTech Innovator and the BioTools Innovator 2025 Cohorts at the invitation-only Innovator Summit on June 25 to 26 in Mountain View, California. This event connects the leadership teams from the latest cohorts with MedTech Innovator’s partners, alumni, and other industry leaders.

Twenty companies from across the globe have been selected for the 2025 MedTech Innovator Asia Pacific Accelerator, including startups from Singapore (2Strands Biosciences), Australia (Australis Scientific), Japan (B dot Medical), the United States (Hemotag), Thailand (OsseoLabs), and Germany (VesselSens).

MedTech Innovator APAC’s 2025 programme sponsors include Johnson & Johnson MedTech, B. Braun Medical, Becton Dickinson, Teleflex, Siemens Healthineers, Cambridge Consultants, and Enterprise Singapore.

The programme will culminate with its first-ever self-hosted Showcase and Grand Finals in Singapore at the end of October.

-- BERNAMA